Clinical Trial

Prostate Metabolism, Cancer Risk and Gut Microbiota

Study acronym: PROMIC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 3, 2023 (before its estimated January 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single center translational multiple cohort study to investigate the association of gut microbiota and prostate cancer.
Trial Details
NCT Number NCT06116851
Lead Sponsor Turku University Hospital
Collaborators: University of Turku
Conditions Prostate Cancer, Prostate Hyperplasia
Enrollment 300 participants
Start Date 2022-06-01
Primary Completion 2024-01-15 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2023-11-03